Cart
sales@molnova.com
Home - Products - Endocrinology/Hormones - RAAS - Valsartan Methyl Ester

Valsartan Methyl Ester

CAS No. 137863-17-3

Valsartan Methyl Ester( —— )

Catalog No. M36024 CAS No. 137863-17-3

Valsartan Methyl Ester is a potent angiotensin II receptor antagonist, IC50= 0.06uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 58 In Stock
5MG 89 In Stock
10MG 136 In Stock
25MG 228 In Stock
50MG 325 In Stock
100MG 462 In Stock
200MG 624 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Valsartan Methyl Ester
  • Note
    Research use only, not for human use.
  • Brief Description
    Valsartan Methyl Ester is a potent angiotensin II receptor antagonist, IC50= 0.06uM.
  • Description
    Valsartan Methyl Ester is a potent angiotensin II receptor antagonist, IC50= 0.06uM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    RAAS
  • Recptor
    RAAS
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    137863-17-3
  • Formula Weight
    449.55
  • Molecular Formula
    C25H31N5O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1)[C@@H](C(C)C)C(=O)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Irbesartan

    Irbesartan is an angiotensin receptor blocker (ARB) used mainly for the treatment of hypertension.

  • Eprosartan Mesylate

    Eprosartan is a nonpeptide angiotensin II receptor antagonist.

  • N-Acetyl-Ser-Asp-Lys...

    Acetyl Ser-Asp-Lys-Pro is formed in bone marrow cells by enzymatic processing of thymosin β4. It inhibits the entry of pluripotent hemopoietic stem cells into S-phase of the cell cycle and protects against Ara-C lethality in mice.N-Acetyl-Ser-Asp-Lys-Pro (AcSDKP) is a specific substrate for the N-terminal site of ACE and increases 5-fold during ACE inhibitor therapy.??AcSDKP inhibited the proliferation of isolated cardiac fibroblasts (P<0.05) but significantly stimulated the proliferation of vascular smooth muscle cells.?

Sign In Join Free